REGISTERED NUMBER: 07982358 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

OCUMEDICA LIMITED

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

3

DIRECTOR:

Dr T Ressiniotis

REGISTERED OFFICE:

573 Chester Road

Sutton Coldfield

West Midlands

B73 5HU

REGISTERED NUMBER:

07982358 (England and Wales)

ACCOUNTANTS:

A K Papadamou & Co

Accountants & Tax Advisors

573 Chester Road

Sutton Coldfield

West Midlands

B73 5HU

BANKERS:

HSBC Bank PLC

67 The Parade

Sutton Coldfield

West Midlands

B72 1PU

FIXED ASSETS

Intangible assets

4

13,000

15,000

Tangible assets

5

11,978

11,092

Investments

6

99,827

99,827

124,805

125,919

CURRENT ASSETS

Debtors

7

754,325

787,015

Cash at bank

403,994

238,064

1,158,319

1,025,079

CREDITORS

Amounts falling due within one year

8

50,542

63,942

NET CURRENT ASSETS

1,107,777

961,137

TOTAL ASSETS LESS CURRENT LIABILITIES

1,232,582

1,087,056

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

1,232,482

1,086,956

SHAREHOLDERS' FUNDS

1,232,582

1,087,056

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 December 2025 and were signed by:

Dr T Ressiniotis - Director

1.	STATUTORY INFORMATION

Ocumedica Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents gross income receivable from services supplied.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 1 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

20,000

AMORTISATION

At 1 April 2024

5,000

Charge for year

2,000

At 31 March 2025

7,000

NET BOOK VALUE

At 31 March 2025

13,000

At 31 March 2024

15,000

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

23,748

Additions

2,995

At 31 March 2025

26,743

DEPRECIATION

At 1 April 2024

12,656

Charge for year

2,109

At 31 March 2025

14,765

NET BOOK VALUE

At 31 March 2025

11,978

At 31 March 2024

11,092

6.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 April 2024

and 31 March 2025

99,827

NET BOOK VALUE

At 31 March 2025

99,827

At 31 March 2024

99,827

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

605,692

509,995

Directors' current accounts

123,409

255,399

Prepayments and accrued income

25,224

21,621

754,325

787,015

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

49,610

62,985

Other creditors

932

957

50,542

63,942